Final answer:
Reducing the prices of pharmaceuticals is not an example of painless cost control because it can have negative consequences for pharmaceutical companies and healthcare providers.
Step-by-step explanation:
No, reducing the prices of pharmaceuticals is not an example of painless cost control.
Price reductions in pharmaceuticals can have several implications. While it may benefit consumers by making medications more affordable, it can also have negative consequences for other stakeholders such as pharmaceutical companies and healthcare providers.
For instance, reducing the prices of pharmaceuticals can lead to decreased revenue for pharmaceutical companies. This can potentially impact their ability to invest in research and development for new drugs, which may hinder medical advancements in the long run.